ALRTF (ALR Technologies SG) Interest Coverage : 0 (At Loss) (As of Dec. 2024)

View and export this data going back to 1998. Start your Free Trial

What is ALR Technologies SG Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. ALR Technologies SG's Operating Income for the six months ended in Dec. 2024 was $-1.34 Mil. ALR Technologies SG's Interest Expense for the six months ended in Dec. 2024 was $-8.54 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for ALR Technologies SG's Interest Coverage or its related term are showing as below:

ALRTF's Interest Coverage is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 17.2
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ALR Technologies SG Interest Coverage Historical Data

The historical data trend for ALR Technologies SG's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

ALR Technologies SG Interest Coverage Chart

ALR Technologies SG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Coverage

Get a 7-Day Free Trial

ALR Technologies SG Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Coverage	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ALR Technologies SG's Interest Coverage

For the Medical Devices subindustry, ALR Technologies SG's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ALR Technologies SG's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ALR Technologies SG's Interest Coverage distribution charts can be found below:

* The bar in red indicates where ALR Technologies SG's Interest Coverage falls into.

Save Embed

;

Save Embed

;

ALR Technologies SG Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ALR Technologies SG's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, ALR Technologies SG's Interest Expense was $-12.42 Mil. Its Operating Income was $-3.50 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

ALR Technologies SG did not have earnings to cover the interest expense.

ALR Technologies SG's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the six months ended in Dec. 2024, ALR Technologies SG's Interest Expense was $-8.54 Mil. Its Operating Income was $-1.34 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

ALR Technologies SG did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's Financial Strength is.

ALR Technologies SG (OTCPK:ALRTF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

ALR Technologies SG Interest Coverage Related Terms

Thank you for viewing the detailed overview of ALR Technologies SG's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

ALR Technologies SG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ALR Technologies SG Ltd (OTCPK:ALRTF) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Raffles Place, No. 26-01 Republic Plaza, Singapore, SGP, 048619

Website

https://www.alrt.com

ALR Technologies SG Ltd is a medical device company that focuses on commercializing its Health-e-Connect System. The company is a data management company that developed a comprehensive approach to diabetes care that includes an FDA-cleared and HIPAA-compliant Diabetes Solution product that can collect data from BGM and CGM; a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. Its geographical segments are the United States, which derives maximum revenue, Singapore, and Others.

Executives

Sidney Chan	director, officer: CEO	7400 BEAUFONT SPRINGS DRIVE, SUITE 300, SUITE 300, RICHMOND VA 23225
Ronald Cheng	director	255 SPRINGFIELD ROAD, OTTAWA A6 K1M 0K8
Peter H Stafford	director	1-405 81ST STREET, OSOYOOS A1 V0H 1V2
William S Smith	director, officer: Chief Commercial Officer	46 CHESTNUT HILL ROAD, WILTON CT 06897
Kenneth Robulak	director	521 MANDALAY AVENUE, APT. 302, CLEARWATER FL 33767
Alfonso Salas	director	2106 WEST 33RD AVENUE, VANCOUVER A1 V6M 1B9
Lawrence A Weinstein	director, officer: President	13436 BLUE HEON LOOP, CHESTERFIELD VA 23838
Jaroslav V Tichy	officer: Vice-President - Technologies	114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106
Stanley Cruitt	director, 10 percent owner, officer: President	114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106